fusidic acid 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 1261 | 6990-06-3 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
An antibiotic isolated from the fermentation broth of Fusidium coccineum. (From Merck Index, 11th ed). It acts by inhibiting translocation during protein synthesis.
|
Drug dosage:
| Dose | Unit | Route |
|---|---|---|
| 1.50 | g | O |
| 1.50 | g | P |
ADMET properties:
| Property | Value | Reference |
|---|---|---|
| BDDCS (Biopharmaceutical Drug Disposition Classification System) | 1 | Bocci G, Oprea TI, Benet LZ |
| BA (Bioavailability) | 91 % | Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H |
| S (Water solubility) | 50 mg/mL | Bocci G, Oprea TI, Benet LZ |
Approvals:
None
FDA Adverse Event Reporting System (Female)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Eczema herpeticum | 50.73 | 24.46 | 8 | 1945 | 161 | 63486908 |
| Biliary sepsis | 48.61 | 24.46 | 10 | 1943 | 921 | 63486148 |
| Monocytosis | 41.13 | 24.46 | 8 | 1945 | 554 | 63486515 |
| Rash maculo-papular | 38.37 | 24.46 | 19 | 1934 | 31877 | 63455192 |
| Rhabdomyolysis | 38.05 | 24.46 | 21 | 1932 | 43930 | 63443139 |
| Scab | 35.28 | 24.46 | 12 | 1941 | 7751 | 63479318 |
| Hyperlipasaemia | 33.39 | 24.46 | 7 | 1946 | 706 | 63486363 |
| Ulcerative keratitis | 33.24 | 24.46 | 9 | 1944 | 2701 | 63484368 |
| Vulvovaginal inflammation | 32.26 | 24.46 | 7 | 1946 | 832 | 63486237 |
| Exposure to SARS-CoV-2 | 32.08 | 24.46 | 8 | 1945 | 1743 | 63485326 |
| Corneal neovascularisation | 31.19 | 24.46 | 5 | 1948 | 112 | 63486957 |
| Dermatitis allergic | 30.78 | 24.46 | 13 | 1940 | 15135 | 63471934 |
| Impetigo | 28.97 | 24.46 | 7 | 1946 | 1339 | 63485730 |
| Reperfusion arrhythmia | 27.52 | 24.46 | 5 | 1948 | 239 | 63486830 |
| Erythema | 26.97 | 24.46 | 30 | 1923 | 175721 | 63311348 |
| Eye inflammation | 26.80 | 24.46 | 9 | 1944 | 5590 | 63481479 |
FDA Adverse Event Reporting System (Male)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Rhabdomyolysis | 194.68 | 29.13 | 82 | 1450 | 68081 | 34887318 |
| Drug interaction | 60.68 | 29.13 | 61 | 1471 | 225885 | 34729514 |
| Chromaturia | 56.73 | 29.13 | 22 | 1510 | 14498 | 34940901 |
| Labelled drug-drug interaction medication error | 52.62 | 29.13 | 21 | 1511 | 14918 | 34940481 |
| Myalgia | 41.11 | 29.13 | 32 | 1500 | 84078 | 34871321 |
FDA Adverse Event Reporting System (Geriatric)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Rhabdomyolysis | 224.96 | 20.54 | 104 | 3501 | 103027 | 79637756 |
| Drug interaction | 64.31 | 20.54 | 86 | 3519 | 415097 | 79325686 |
| Labelled drug-drug interaction medication error | 51.22 | 20.54 | 25 | 3580 | 27625 | 79713158 |
| Eczema herpeticum | 49.27 | 20.54 | 9 | 3596 | 299 | 79740484 |
| Rash maculo-papular | 41.88 | 20.54 | 28 | 3577 | 56050 | 79684733 |
| Biliary sepsis | 39.27 | 20.54 | 10 | 3595 | 1607 | 79739176 |
| Scab | 37.20 | 20.54 | 15 | 3590 | 10557 | 79730226 |
| Cholestasis | 34.13 | 20.54 | 24 | 3581 | 52085 | 79688698 |
| Monocytosis | 33.27 | 20.54 | 8 | 3597 | 1016 | 79739767 |
| Chromaturia | 32.50 | 20.54 | 18 | 3587 | 25728 | 79715055 |
| Exposure to SARS-CoV-2 | 27.79 | 20.54 | 8 | 3597 | 2036 | 79738747 |
| Corneal neovascularisation | 27.58 | 20.54 | 5 | 3600 | 159 | 79740624 |
| Ulcerative keratitis | 27.07 | 20.54 | 9 | 3596 | 3680 | 79737103 |
| Hyperlipasaemia | 26.78 | 20.54 | 7 | 3598 | 1247 | 79739536 |
| Dermatitis allergic | 26.58 | 20.54 | 14 | 3591 | 18116 | 79722667 |
| Reperfusion arrhythmia | 24.57 | 20.54 | 5 | 3600 | 295 | 79740488 |
| Vitamin K decreased | 24.25 | 20.54 | 4 | 3601 | 72 | 79740711 |
| Impetigo | 23.26 | 20.54 | 7 | 3598 | 2076 | 79738707 |
| Erythema | 22.58 | 20.54 | 38 | 3567 | 223252 | 79517531 |
| Eye inflammation | 22.22 | 20.54 | 9 | 3596 | 6404 | 79734379 |
| Gastrointestinal submucosal tumour | 22.07 | 20.54 | 4 | 3601 | 127 | 79740656 |
| Myalgia | 22.05 | 20.54 | 34 | 3571 | 185607 | 79555176 |
| Vulvovaginal inflammation | 21.58 | 20.54 | 5 | 3600 | 541 | 79740242 |
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | D06AX01 | DERMATOLOGICALS ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE ANTIBIOTICS FOR TOPICAL USE Other antibiotics for topical use |
| ATC | D09AA02 | DERMATOLOGICALS MEDICATED DRESSINGS MEDICATED DRESSINGS Medicated dressings with antiinfectives |
| ATC | J01XC01 | ANTIINFECTIVES FOR SYSTEMIC USE ANTIBACTERIALS FOR SYSTEMIC USE OTHER ANTIBACTERIALS Steroid antibacterials |
| ATC | S01AA13 | SENSORY ORGANS OPHTHALMOLOGICALS ANTIINFECTIVES Antibiotics |
| MeSH PA | D000900 | Anti-Bacterial Agents |
| MeSH PA | D000890 | Anti-Infective Agents |
| MeSH PA | D004791 | Enzyme Inhibitors |
| MeSH PA | D011500 | Protein Synthesis Inhibitors |
| CHEBI has role | CHEBI:48001 | protein synthesis inhibitors |
| CHEBI has role | CHEBI:76971 | Escherichia coli metabolites |
| CHEBI has role | CHEBI:77194 | ATP:pantothenate 4-phosphotransferase inhibitor |
Drug Use | Suggest Off label Use Form| |View source of the data|
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Trachoma | indication | 2576002 | DOID:11265 |
| Listeriosis | indication | 4241002 | DOID:11573 |
| Septicemia due to Escherichia coli | indication | 9323009 | |
| Bacterial septicemia | indication | 10001005 | DOID:0040085 |
| Infection due to Pseudomonas aeruginosa | indication | 11218009 | |
| Inhalational anthrax | indication | 11389007 | |
| Actinomycotic infection | indication | 11817007 | DOID:8478 |
| Folliculitis | indication | 13600006 | DOID:4409 |
| Gonorrhea | indication | 15628003 | DOID:7551 |
| Pneumococcal infectious disease | indication | 16814004 | |
| Tularemia | indication | 19265001 | |
| Infection of skin AND/OR subcutaneous tissue | indication | 19824006 | |
| Gingivostomatitis | indication | 20607006 | |
| Acute gonococcal cervicitis | indication | 20943002 | DOID:10615 |
| Staphylococcal pneumonia | indication | 22754005 | |
| Murine typhus | indication | 25668000 | DOID:11256 |
| Granuloma inguinale | indication | 28867007 | DOID:9113 |
| Acute gonococcal urethritis | indication | 29864006 | |
| Acute gonococcal epididymo-orchitis | indication | 30168008 | DOID:10802 |
| Bronchitis | indication | 32398004 | DOID:6132 |
| Sinusitis | indication | 36971009 | |
| Disease caused by rickettsiae | indication | 37246009 | |
| Louse-borne typhus | indication | 39111003 | DOID:11256 |
| Pneumonia due to Pseudomonas | indication | 41381004 | |
| Punctate keratitis | indication | 42513006 | DOID:12197 |
| Gonorrhea of rectum | indication | 42746002 | |
| Pneumonia due to Mycoplasma pneumoniae | indication | 46970008 | |
| Brill-Zinsser disease | indication | 47761007 | DOID:11254 |
| Peritonitis | indication | 48661000 | |
| Pneumonia due to Escherichia coli | indication | 51530003 | |
| Bacterial pneumonia | indication | 53084003 | DOID:874 |
| Staphylococcal infectious disease | indication | 56038003 | |
| Cholera | indication | 63650001 | DOID:1498 |
| Acute gonococcal endometritis | indication | 65295003 | DOID:7527 |
| Urinary tract infectious disease | indication | 68566005 | |
| Blepharoconjunctivitis | indication | 68659002 | DOID:2456 |
| Yaws | indication | 70647001 | DOID:10371 |
| Infection due to Escherichia coli | indication | 71057007 | |
| Bacterial infection due to Serratia | indication | 71120004 | |
| Paronychia | indication | 71906005 | DOID:13117 |
| Rhinoscleroma | indication | 72409005 | DOID:11336 |
| Gonorrhea of pharynx | indication | 74372003 | |
| Perforation of cornea | indication | 74895004 | |
| Rickettsialpox | indication | 75096007 | DOID:11103 |
| Ornithosis | indication | 75116005 | DOID:11262 |
| Acute bacterial sinusitis | indication | 75498004 | |
| Brucellosis | indication | 75702008 | DOID:11077 |
| Syphilis | indication | 76272004 | |
| Septicemia due to Serratia | indication | 82091000 | |
| Cholangitis | indication | 82403002 | DOID:9446 |
| Nongonococcal urethritis | indication | 84619001 | |
| Cutaneous anthrax | indication | 84980006 | DOID:7426 |
| Streptococcal infectious disease | indication | 85769006 | |
| Dacryocystitis | indication | 85777005 | DOID:9938 |
| Corneal abrasion | indication | 85848002 | |
| Keratoconjunctivitis | indication | 88151007 | DOID:9368 |
| Acne vulgaris | indication | 88616000 | |
| Bacterial meningitis | indication | 95883001 | DOID:9470 |
| Q fever endocarditis | indication | 95890006 | |
| Chlamydial infection | indication | 105629000 | |
| Infection of bone | indication | 111253001 | |
| Gastrointestinal anthrax | indication | 111798006 | DOID:13386 |
| Furunculosis | indication | 112650006 | |
| Infectious disease of abdomen | indication | 128070006 | |
| Bacterial conjunctivitis | indication | 128350005 | DOID:9700 |
| Uveitis | indication | 128473001 | DOID:13141 |
| Bacterial infection of skin | indication | 128936008 | |
| Infection due to Enterobacteriaceae | indication | 128945009 | |
| Bacterial infection due to Klebsiella pneumoniae | indication | 186435004 | |
| Rocky Mountain spotted fever | indication | 186772009 | |
| Boutonneuse fever | indication | 186774005 | DOID:14095 |
| Q fever | indication | 186788009 | DOID:11100 |
| Lymphogranuloma venereum | indication | 186946009 | DOID:13819 |
| Proteus pneumonia | indication | 195888009 | |
| Bacterial peritonitis | indication | 197171003 | |
| Sepsis of the newborn | indication | 206376005 | |
| Pneumonia | indication | 233604007 | DOID:552 |
| Neonatal pneumonia | indication | 233619008 | |
| Inclusion conjunctivitis | indication | 266109000 | |
| Bartonellosis | indication | 266123003 | DOID:11102 |
| Chancroid | indication | 266143009 | DOID:13778 |
| Scrub typhus | indication | 271425001 | DOID:13371 |
| Neonatal meningitis | indication | 276674008 | |
| Proteus septicemia | indication | 300986008 | |
| Escherichia coli urinary tract infection | indication | 301011002 | |
| Meibomianitis | indication | 309779001 | |
| Bacterial urinary infection | indication | 312124009 | |
| Infective otitis media | indication | 312218008 | |
| Infective blepharitis | indication | 312219000 | |
| Bacterial keratitis | indication | 314557000 | |
| Infectious disorder of joint | indication | 363162000 | |
| Herpes zoster keratitis | indication | 397573005 | |
| Rosacea | indication | 398909004 | DOID:8881 |
| Pharyngitis | indication | 405737000 | DOID:2275 |
| Infection due to Staphylococcus aureus | indication | 406602003 | |
| Anthrax | indication | 409498004 | DOID:7427 |
| Anterior uveitis | indication | 410692006 | DOID:1407 |
| Relapsing fever | indication | 420079008 | DOID:13034 |
| Nosocomial pneumonia | indication | 425464007 | |
| Chlamydia trachomatis infection of genital structure | indication | 428015005 | |
| Osteomyelitis due to Staphylococcus aureus | indication | 428783003 | |
| Sepsis due to Pseudomonas | indication | 448813005 | |
| Sepsis due to Gram negative bacteria | indication | 449082003 | |
| Allergic conjunctivitis | indication | 473460002 | DOID:11204 |
| Urinary tract infection caused by Klebsiella | indication | 369001000119100 | |
| Disseminated Gonococcal Infection | indication | ||
| Complicated Proteus UTI | indication | ||
| Synergy for Staphylococcal Joint Infection | indication | ||
| Providencia Complicated UTI | indication | ||
| Superficial Ocular Infection | indication | ||
| Synergy for Group B Streptococcal Septicemia | indication | ||
| Synergy for Staphylococcal Endocarditis | indication | ||
| Synergy for Pseudomonas Aeruginosa Septicemia | indication | ||
| Synergy for Pseudomonas Aeruginosa Pneumonia | indication | ||
| Synergy for Serratia Meningitis | indication | ||
| E. Coli Osteomyelitis | indication | ||
| Burn Wound Infections | indication | ||
| Klebsiella Pneumoniae Peritonitis | indication | ||
| Skin and Skin Structure Citrobacter Infection | indication | ||
| Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention | indication | ||
| Pseudomonas Aeruginosa Biliary Tract Infection | indication | ||
| Citrobacter Septicemia | indication | ||
| Synergy for Skin and Skin Structure Pseudomonas Aeruginosa Infection | indication | ||
| Synergy for Pseudomonas Aeruginosa Osteomyelitis | indication | ||
| Skin and Skin Structure Serratia Infection | indication | ||
| Citrobacter Complicated UTI | indication | ||
| Synergy for Staphylococcal Septicemia | indication | ||
| Synergy for Pseudomonas Aeruginosa Meningitis | indication | ||
| Serratia Complicated UTI | indication | ||
| Staphylococcus Aureus Complicated UTI | indication | ||
| Synergy for Neonatal Meningitis | indication | ||
| Synergy for Escherichia Coli Meningitis | indication | ||
| Enterobacter Osteomyelitis | indication | ||
| Complicated Bacterial Peritonitis | indication | ||
| Gram-Negative Aerobic Bacillary Pneumonia | indication | ||
| Synergy for Nosocomial Pneumonia due to Pseudomonas Aeruginosa | indication | ||
| Pseudomonas Aeruginosa Joint Infection | indication | ||
| Synergy for Staphylococcus Aureus Pneumonia | indication | ||
| Synergy for Klebsiella Meningitis | indication | ||
| Rectal Chlamydia Trachomatis Infection | indication | ||
| Skin and Skin Structure Pseudomonas Aeruginosa Infection | indication | ||
| Pseudomonas Aeruginosa Osteomyelitis | indication | ||
| Synergy for Bacterial Meningitis | indication | ||
| Synergy for P. Aeruginosa Infection in Cystic Fibrosis | indication | ||
| Pseudomonas Aeruginosa Meningitis | indication | ||
| Proteus Mirabilis Osteomyelitis | indication | ||
| Citrobacter Pneumonia | indication | ||
| Synergy for Proteus Meningitis | indication | ||
| Synergy for Pseudomonas Aeruginosa Joint Infection | indication | ||
| Synergy for Staphylococcus Skin and Skin Structure Infection | indication | ||
| Klebsiella Septicemia | indication | ||
| Complicated UTI with Pseudomonas Aeruginosa | indication | ||
| Typhus Infections | indication | ||
| Synergy for Staphylococcal Infections | indication | ||
| Enterobacter Pneumonia | indication | ||
| Klebsiella Pneumoniae Osteomyelitis | indication | ||
| Complicated Urinary Tract Infections | indication | ||
| Synergy for Enterobacter Meningitis | indication | ||
| E. Coli Peritonitis | indication | ||
| Skin and Skin Structure Proteus Infection | indication | ||
| Synergy for Citrobacter Meningitis | indication | ||
| Necrotizing enterocolitis in fetus OR newborn | off-label use | 2707005 | |
| Pyrexia of unknown origin | off-label use | 7520000 | |
| Traveler's diarrhea | off-label use | 11840006 | |
| Exposure keratoconjunctivitis | off-label use | 14366000 | DOID:9461 |
| Ecthyma gangrenosum | off-label use | 17732003 | |
| Enteric campylobacteriosis | off-label use | 18081009 | |
| Lyme disease | off-label use | 23502006 | DOID:11729 |
| Vivax malaria | off-label use | 27052006 | DOID:12978 |
| Lyme arthritis | off-label use | 33937009 | |
| Pseudotuberculosis | off-label use | 36753006 | |
| Enterocolitis | off-label use | 43752006 | |
| Plague | off-label use | 58750007 | DOID:3482 |
| Malaria | off-label use | 61462000 | DOID:12365 |
| Ehrlichiosis | off-label use | 77361002 | |
| Leptospirosis | off-label use | 77377001 | DOID:2297 |
| Lyme carditis | off-label use | 77863005 | |
| Infection by Yersinia enterocolitica | off-label use | 80960004 | |
| Atypical mycobacterial infection | off-label use | 111812000 | |
| Infection by Campylobacter fetus | off-label use | 111835002 | |
| Ocular rosacea | off-label use | 200933006 | |
| Neuropathic corneal ulcer | off-label use | 231901007 | |
| Chlamydial epididymitis | off-label use | 236767000 | |
| Synergy for Enterococcal Endocarditis | off-label use | ||
| Sexual Transmitted Disease Exposure from Sexual Assault | off-label use | ||
| Listeria Monocytogenes Septicemia | off-label use | ||
| Synergy for Enterococcal Infections | off-label use | ||
| Postexposure Plague Prophylaxis | off-label use | ||
| Lyme Disease Prevention | off-label use | ||
| Synergy for Prevention of Enterococcal Endocarditis | off-label use | ||
| Periodontitis Adjunct Therapy | off-label use | ||
| Chloroquine Resistant Plasmodium Falciparum Malaria | off-label use | ||
| Pseudomonas Respiratory Tract Infection in Cystic Fibrosis | off-label use | ||
| Synergy for Streptococcal Endocarditis | off-label use | ||
| Pleural Malignant Effusions | off-label use | ||
| Synergy for Listeria Monocytogenes Septicemia | off-label use | ||
| Prevention of Perioperative Infection | off-label use | ||
| Ocular hypertension | contraindication | 4210003 | DOID:9282 |
| Hypocalcemia | contraindication | 5291005 | |
| Herpes simplex keratitis | contraindication | 9389005 | |
| Glaucoma | contraindication | 23986001 | DOID:1686 |
| Complete atrioventricular block | contraindication | 27885002 | |
| Shock | contraindication | 27942005 | |
| Hypovolemia | contraindication | 28560003 | |
| Herpes simplex dendritic keratitis | contraindication | 29943008 | |
| Fungal infection of eye | contraindication | 31194008 | |
| Parkinsonism | contraindication | 32798002 | |
| Dehydration | contraindication | 34095006 | |
| Severe myopia | contraindication | 34187009 | |
| Hypokalemia | contraindication | 43339004 | |
| Stokes-Adams syndrome | contraindication | 46935006 | |
| Chronic heart failure | contraindication | 48447003 | |
| Tuberculosis of eye | contraindication | 49107007 | |
| Atrial fibrillation | contraindication | 49436004 | DOID:0060224 |
| Sinus bradycardia | contraindication | 49710005 | |
| Disorder of digestive system | contraindication | 53619000 | DOID:77 |
| Acute nephropathy | contraindication | 58574008 | |
| Hepatic failure | contraindication | 59927004 | |
| Tinnitus | contraindication | 60862001 | |
| Colitis | contraindication | 64226004 | DOID:0060180 |
| Diabetes mellitus | contraindication | 73211009 | DOID:9351 |
| Wolff-Parkinson-White pattern | contraindication | 74390002 | DOID:384 |
| Decreased respiratory function | contraindication | 80954004 | |
| Open-angle glaucoma | contraindication | 84494001 | DOID:1067 |
| Krukenberg spindle | contraindication | 85430004 | |
| Herpes zoster ophthalmicus | contraindication | 87513003 | |
| Kidney disease | contraindication | 90708001 | DOID:557 |
| Myasthenia gravis | contraindication | 91637004 | DOID:437 |
| Eye infection | contraindication | 128351009 | |
| Bacterial infection of eye | contraindication | 128984004 | |
| Hypomagnesemia | contraindication | 190855004 | |
| Partial atrioventricular block | contraindication | 195039008 | |
| Disease of liver | contraindication | 235856003 | DOID:409 |
| Esophageal dysmotility | contraindication | 266434009 | DOID:9192 |
| Pregnancy, function | contraindication | 289908002 | |
| Viral eye infection | contraindication | 312132001 | |
| Hypoxia | contraindication | 389086002 | |
| Vaccinia keratitis | contraindication | 397552005 | |
| Pseudomembranous enterocolitis | contraindication | 397683000 | |
| Vertigo | contraindication | 399153001 | |
| Breastfeeding (mother) | contraindication | 413712001 | |
| Denuded skin | contraindication | 418242004 | |
| Gentamicin Toxicity | contraindication | ||
| Reduced Hepatic Blood Flow | contraindication | ||
| Disorder of the 8th Cranial Nerve | contraindication | ||
| Infant Botulism | contraindication | ||
| Tobramycin Toxicity | contraindication | ||
| Lidocaine Toxicity | contraindication |
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 4.75 | acidic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| ATP-binding cassette sub-family G member 2 | Transporter | IC50 | 4.28 | CHEMBL | |||||
| Bile salt export pump | Transporter | IC50 | 4.94 | CHEMBL | |||||
| Bile salt export pump | Transporter | IC50 | 4.76 | CHEMBL |
External reference:
| ID | Source |
|---|---|
| N0000167438 | NUI |
| D00213 | KEGG_DRUG |
| C0016875 | UMLSCUI |
| CHEBI:29013 | CHEBI |
| FUA | PDB_CHEM_ID |
| CHEMBL374975 | ChEMBL_ID |
| D005672 | MESH_DESCRIPTOR_UI |
| DB02703 | DRUGBANK_ID |
| 10815 | IUPHAR_LIGAND_ID |
| 1431 | INN_ID |
| 59XE10C19C | UNII |
| 3000226 | PUBCHEM_CID |
| 202636 | RXNORM |
| 003486 | NDDF |
| 003488 | NDDF |
| 387530003 | SNOMEDCT_US |
| 395876005 | SNOMEDCT_US |
| 96015006 | SNOMEDCT_US |
| CHEMBL1256987 | ChEMBL_ID |
Pharmaceutical products:
None